Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Desirability and feasibility of a vaccine against cytomegalovirus.

Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S.

Vaccine. 2013 Apr 18;31 Suppl 2:B197-203. doi: 10.1016/j.vaccine.2012.10.074. Review.

PMID:
23598482
2.

The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

McCormick AL, Mocarski ES.

Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Review.

3.

Cytomegalovirus vaccine: phase II clinical trial results.

Rieder F, Steininger C.

Clin Microbiol Infect. 2014 May;20 Suppl 5:95-102. doi: 10.1111/1469-0691.12449. Review.

4.

Development of a cytomegalovirus vaccine: lessons from recent clinical trials.

Gonczol E, Plotkin S.

Expert Opin Biol Ther. 2001 May;1(3):401-12. Review.

PMID:
11727514
5.

CMV vaccine trial endpoints.

Griffiths PD.

J Clin Virol. 2009 Dec;46 Suppl 4:S64-7. doi: 10.1016/j.jcv.2009.10.003.

PMID:
19879802
6.

Priorities for CMV vaccine development.

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA.

Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Review.

7.

Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.

Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M.

Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014.

8.

Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US.

Alfaro-Murillo JA, Townsend JP, Galvani AP.

Vaccine. 2016 Jan 4;34(2):225-9. doi: 10.1016/j.vaccine.2015.11.039.

PMID:
26631416
9.

Progress in cytomegalovirus vaccine development.

Schleiss M.

Herpes. 2005 Dec;12(3):66-75. Review.

PMID:
16393522
10.

Immunization to prevent congenital cytomegalovirus infection.

Adler SP.

Br Med Bull. 2013;107:57-68. doi: 10.1093/bmb/ldt023. Review.

PMID:
23954939
11.

Progress toward an elusive goal: current status of cytomegalovirus vaccines.

Schleiss MR, Heineman TC.

Expert Rev Vaccines. 2005 Jun;4(3):381-406. Review.

PMID:
16026251
12.

Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

Pass RF, Burke RL.

Semin Pediatr Infect Dis. 2002 Jul;13(3):196-204. Review.

PMID:
12199616
13.

Vaccine prevention of maternal cytomegalovirus infection.

Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G.

N Engl J Med. 2009 Mar 19;360(12):1191-9. doi: 10.1056/NEJMoa0804749.

14.

Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.

Bialas KM, Swamy GK, Permar SR.

Clin Perinatol. 2015 Mar;42(1):61-75, viii. doi: 10.1016/j.clp.2014.10.006. Review.

15.

Strategies to prevent CMV infection in the neonate.

Griffiths PD.

Semin Neonatol. 2002 Aug;7(4):293-9. Review.

PMID:
12401299
16.

Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.

Dasari V, Smith C, Khanna R.

Expert Rev Vaccines. 2013 Jun;12(6):661-76. doi: 10.1586/erv.13.46. Review.

PMID:
23750795
17.

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.

Swanson EC, Gillis P, Hernandez-Alvarado N, Fernández-Alarcón C, Schmit M, Zabeli JC, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2015 Jul 31;33(32):4013-8. doi: 10.1016/j.vaccine.2015.06.019.

18.

Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

Colugnati FA, Staras SA, Dollard SC, Cannon MJ.

BMC Infect Dis. 2007 Jul 2;7:71.

19.

Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.

Schleiss MR, Choi KY, Anderson J, Mash JG, Wettendorff M, Mossman S, Van Damme M.

Vaccine. 2014 May 13;32(23):2756-62. doi: 10.1016/j.vaccine.2013.07.010.

20.

Immunoprophylaxis against cytomegalovirus disease.

Adler SP.

Scand J Infect Dis Suppl. 1995;99:105-9. Review.

PMID:
8668931
Items per page

Supplemental Content

Support Center